Trials / Completed
CompletedNCT02597712
YF476 in Barrett's Esophagus
Randomized, Placebo-controlled Trial of YF476, a Gastrin Receptor Antagonist, in Barrett's Esophagus
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Trio Medicines Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A phase 2, randomised, double-blind, out-patient trial to determine if YF476 is a safe and effective treatment in patients with Barrett's esophagus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YF476 | gastrin receptor antagonist |
| DRUG | YF476 placebo | placebo |
Timeline
- Start date
- 2013-05-15
- Primary completion
- 2017-11-28
- Completion
- 2017-12-27
- First posted
- 2015-11-05
- Last updated
- 2021-04-12
- Results posted
- 2021-04-12
Locations
2 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT02597712. Inclusion in this directory is not an endorsement.